{"id":"das181-f02-dry-powder-in-bulk","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL2109052","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to Siglec-9, DAS181-F02 Dry Powder in Bulk inhibits the activation of immune cells, thereby reducing inflammation and potentially treating respiratory syncytial virus (RSV) infections.","oneSentence":"DAS181-F02 Dry Powder in Bulk is a fusion protein that targets the sialic acid-binding immunoglobulin-like lectin 9 (Siglec-9) receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:15.169Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of RSV infections"}]},"trialDetails":[{"nctId":"NCT01924793","phase":"PHASE2","title":"An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection","status":"COMPLETED","sponsor":"Ansun Biopharma, Inc.","startDate":"2013-08","conditions":"Parainfluenza","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"DAS181-F02 Dry Powder in Bulk","genericName":"DAS181-F02 Dry Powder in Bulk","companyName":"Ansun Biopharma, Inc.","companyId":"ansun-biopharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DAS181-F02 Dry Powder in Bulk is a fusion protein that targets the sialic acid-binding immunoglobulin-like lectin 9 (Siglec-9) receptor. Used for Treatment of RSV infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}